Badrul became Chief Life Sciences Officer, Smoke-Free Products, in September 2022. He leads a talented team of scientific experts overseeing best-in-class programs to demonstrate the individual, clinical, and public health benefits of PMI’s smoke-free products for adult smokers who would otherwise continue to smoke.
Badrul joined PMI from a U.S.-based biotech company developing inhalation products for rare respiratory diseases, where he was Chief Medical Officer. Prior to that, he was AstraZeneca’s Senior Vice President and Chief Physician-Scientist for Respiratory Inflammation and Autoimmunity Late-Stage Development in Biopharmaceuticals R&D.
Before joining the pharmaceutical industry, Badrul served as Director, Division of Pulmonary, Allergy, and Rheumatology Products, Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration for almost 21 years, from 1997 to 2018, providing scientific and regulatory oversight of therapies for lung, autoimmune, and inflammatory diseases. He is a medical doctor and holds a PhD in immunology from Memorial University of Newfoundland, Canada.